A qualitative assessment of the acceptability of hepatitis C remote self-testing and self-sampling amongst people who use drugs in London, UK

被引:0
作者
Andy Guise
T. Charles Witzel
Sema Mandal
Caroline Sabin
Tim Rhodes
Anthony Nardone
Magdalena Harris
机构
[1] London School of Hygiene and Tropical Medicine,School of Population Health and Environmental Sciences, Guy’s campus
[2] King’s College London,undefined
[3] SIGMA Research,undefined
[4] London School of Hygiene and Tropical Medicine,undefined
[5] Public Health England,undefined
[6] Wellington House,undefined
[7] National Institute for Health Research (NIHR) Health Protection Research Unit (HPRU) in Blood Borne and Sexually Transmitted Infections at UCL in collaboration with Public Health England,undefined
[8] Institute for Global Health,undefined
[9] UCL,undefined
来源
BMC Infectious Diseases | / 18卷
关键词
Hepatitis C; HCV; Remote testing; Self testing; People who use drugs; Rapid assessment; Qualitative;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 142 条
[1]  
Urbanus AT(2009)Hepatitis C virus infections among HIV-infected men who have sex with men: an expanding epidemic AIDS 23 F1-F7
[2]  
van de Laar TJ(2017)Sexual transmission of hepatitis C virus among gay and bisexual men: a systematic review Sex Health 14 28-41
[3]  
Stolte IG(2011)Transmission of HCV in HIV-positive populations Curr Opin HIV AIDS 6 451-458
[4]  
Schinkel J(2016)Sexually acquired hepatitis C virus infection: a review Int J Infect Dis 49 47-58
[5]  
Heijman T(2013)Hepatitis C virus treatment for prevention among people who inject drugs: modeling treatment scale-up in the age of direct-acting antivirals Hepatology 58 1598-1609
[6]  
Coutinho RA(2015)The hepatitis C virus epidemics in key populations (including people who inject drugs, prisoners and MSM): the use of direct-acting antivirals as treatment for prevention Curr Opin HIV AIDS 10 374-380
[7]  
Prins M(2015)Global policy and access to new hepatitis C therapies for people who inject drugs Int J Drug Policy 26 1064-1071
[8]  
Jin F(2013)Elimination of hepatitis C virus infection among people who inject drugs through treatment as prevention: feasibility and future requirements Clin Infect Dis 57 1014-1020
[9]  
Matthews GV(2015)Strategies for the treatment of hepatitis C in an era of interferon-free therapies: what public health outcomes do we value most? Gut 64 1800-342
[10]  
Grulich AE(2017)Elimination of HCV as a public health concern among people who inject drugs by 2030 - what will it take to get there? J Int AIDS Soc 20 22146-26